All In Biotech

Drug Trial Radar · NCT04167670

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection

A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Open-Label Dual Therapy With Oral Vonoprazan 20 mg or Double-Blind Triple Therapy With Oral Vonoprazan 20 mg Compared to Double-Blind Triple Therapy With Oral Lansoprazole 30 mg Daily in Patients With Helicobacter Pylori Infection

Last checked: Nov 19, 2026Latest source record: Apr 5, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,046 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,046

Actual

Start

Dec 10, 2019

Primary completion

Mar 10, 2021

Study completion Mar 18, 2021

Sponsor

Lead sponsor
Phathom Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Nov 19, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the efficacy of Helicobacter pylori (HP) eradication with vonoprazan dual and triple therapy regimens versus lansoprazole triple therapy regimen in participants with HP infection, excluding participants who had a clarithromycin or amoxicillin resistant strain of HP at baseline.

Conditions

  • Helicobacter Pylori Infection

Interventions

  • VonoprazanDrug

    Over-encapsulated tablets administered orally.

  • AmoxicillinDrug

    Capsules administered orally.

  • ClarithromycinDrug

    Tablets administered orally.

  • LansoprazoleDrug

    Over-encapsulated capsules administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Successful Helicobacter Pylori (H Pylori) Eradication in Participants Without a Clarithromycin- or Amoxicillin-resistant Strain of H Pylori at BaselineTime frame: Baseline to 4 weeks after the last dose of study drugs (maximum duration of treatment was 2 weeks)

Locations

153 sites in 6 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • North Alabama Research Center, LLC

    Athens, Alabama

  • Synexus Clinical Research US, Inc. - Alabama

    Birmingham, Alabama

  • Medical Affiliated Research Center Inc

    Huntsville, Alabama

  • Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC

    Chandler, Arizona

  • Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC

    Mesa, Arizona

  • Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC

    Mesa, Arizona

  • Elite Clinical Studies - Phoenix - BTC - PPDS

    Phoenix, Arizona

  • Hope Research Institute LLC

    Phoenix, Arizona

  • Del Sol Research Management - BTC - PPDS

    Tucson, Arizona

  • Preferred Research Partners - ClinEdge - PPDS

    Little Rock, Arkansas

  • Applied Research Center of Little Rock

    Little Rock, Arkansas

  • Arkansas Gastroenterology

    North Little Rock, Arkansas

  • Atria Clinical Research - BTC - PPDS

    North Little Rock, Arkansas

  • Anaheim Clinical Trials LLC

    Anaheim, California

  • GW Research, Inc. - ClinEdge - PPDS

    Chula Vista, California

  • eStudySite - Chula Vista - PPDS

    Chula Vista, California

  • Kindred Medical Institute for Clinical Trials, LLC

    Corona, California

  • HB Clinical Trials, Inc.

    Fountain Valley, California

  • OM Research LLC - Lancaster - ClinEdge - PPDS

    Lancaster, California

  • Torrance Clinical Research Institute

    Lomita, California

  • Southern California Research Institute Medical Group, Inc.

    Los Angeles, California

  • Facey Medical Foundation

    Mission Hills, California

  • Palmtree Clinical Research

    Palm Springs, California

  • Precision Research Institute

    San Diego, California

  • Medical Associates Research Group, Inc.

    San Diego, California

  • Paragon Rx Clinical, Inc.

    Santa Ana, California

  • Synexus Clinical Research US, Inc.

    Colorado Springs, Colorado

  • Western States Clinical Research, Inc.

    Wheat Ridge, Colorado

  • Gastroenterology Associates of Fairfield County

    Bridgeport, Connecticut

  • Connecticut Clinical Research Foundation

    Bristol, Connecticut

  • Riverside Clinical Research

    Edgewater, Florida

  • Research Centers of America - ERG

    Hollywood, Florida

  • Nature Coast Clinical Research

    Inverness, Florida

  • ENCORE Borland-Groover Clinical Research - ERN - PPDS

    Jacksonville, Florida

  • Columbus Clinical Services LLC

    Miami, Florida

  • Jesscan Medical Research

    Miami, Florida

  • Nuren Medical and Research Center

    Miami, Florida

  • Premier Research Associate-Miami

    Miami, Florida

  • G. Medical Center

    Orlando, Florida

Showing 40 of 153 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.